# Commission Regulation (EC) No 1646/2004 of 20 September 2004 amending Annex I to Council Regulation (EEC) No 2377/90 laying down a Community procedure for the establishment of maximum residue limits of veterinary medicinal products in foodstuffs of animal origin (Text with EEA relevance), Annex

Extent: E+W+S+N.I.

The following substance(s) is(are) inserted in Annex I:
Pharmacologically active substance(s)
Marker residue
Animal species
MRLs
Target tissues
‘Albendazole
Sum of albendazole sulphoxide, albendazole sulphone, and albendazole 2-amino sulphone, expressed as albendazole
All ruminants
100 μg/kg
Muscle
100 μg/kg
Fat
1 000 μg/kg
Liver
500 μg/kg
Kidney
100 μg/kg
Milk
Febantel
Sum of extractable residues which may be oxidised to oxfendazole sulphone
All ruminants
50 μg/kg
Muscle
50 μg/kg
Fat
500 μg/kg
Liver
50 μg/kg
Kidney
10 μg/kg
Milk
Fenbendazole
Sum of extractable residues which may be oxidised to oxfendazole sulphone
All ruminants
50 μg/kg
Muscle
50 μg/kg
Fat
500 μg/kg
Liver
50 μg/kg
Kidney
10 μg/kg
Milk
Oxfendazole
Sum of extractable residues which may be oxidised to oxfendazole sulphone
All ruminants
50 μg/kg
Muscle
50 μg/kg
Fat
500 μg/kg
Liver
50 μg/kg
Kidney
10 μg/kg
Milk
Thiabendazole
Sum of thiabendazole and 5-hydroxythiabendazole
Caprine
100 μg/kg
Muscle
100 μg/kg
Fat
100 μg/kg
Liver
100 μg/kg
Kidney
100 μg/kg
Milk’
Pharmacologically active substance(s)
Marker residue
Animal species
MRLs
Target tissues
‘Oxyclozanide
Oxyclozanide
All ruminants
20 μg/kg
Muscle
20 μg/kg
Fat
500 μg/kg
Liver
100 μg/kg
Kidney
10 μg/kg
Milk’
Pharmacologically active substance(s)
Marker residue
Animal species
MRLs
Target tissues
‘Amitraz
Sum of amitraz and all metabolites containing the 2,4-dimethylaniline moiety, expressed as amitraz
Caprine
200 μg/kg
Fat
100 μg/kg
Liver
200 μg/kg
Kidney
10 μg/kg
Milk’
Further provisions in Commission Directive 98/82/EC are to be observed (OJ L290, 29.10.1998, p. 25).’
Pharmacologically active substance(s)
Marker residue
Animal species
MRLs
Target tissues
‘Cypermethrin
Cypermethrin (sum of isomers)
All ruminants
20 μg/kg
Muscle
200 μg/kg
Fat
20 μg/kg
Liver
20 μg/kg
Kidney
20 μg/kg
Milk
Deltamethrin
Deltamethrin
All ruminants
10 μg/kg
Muscle
50 μg/kg
Fat
10 μg/kg
Liver
10 μg/kg
Kidney
20 μg/kg
Milk
Pharmacologically active substance(s)
Marker residue
Animal species
MRLs
Target tissues
‘Dexamethasone
Dexamethasone
Caprine
0,75 μg/kg
Muscle
2 μg/kg
Liver
0,75 μg/kg
Kidney
0,3 μg/kg
Milk’

---
Source: https://www.legislation.gov.uk/eur/2004/1646/annex (the official version)
Page: https://openlegislation.uk/eu-regulation-2004-1646/annex
Contains public sector information licensed under the Open Government Licence v3.0. Source: legislation.gov.uk, The National Archives.

